PPT-TRIPLE ABC Technique in clinical assessment in breast cancer diagnosis

By Prof Dr Sribatsa Kumar Mohapatra MS FRCS FAIS DNB amp Prof Dr Brajamohan Mishra VSS Institute of Medical Sciences amp Research . Lauren Barney. April 17, 2013. Breast Cancer Subtypes. Breast cancer is classified into clinical subtypes based upon receptor expression. These subtypes dictate possible therapeutic options and vary in their prognosis. SYMPTOMS/LUMPS. Professor P Grantley Gill. Specialists Without Borders. Seminar in Surgery . Rwanda, September 2010. SIGNS AND SYMPTOMS AT PRESENTATION. Palpable mass. Thickening, Pain. . Mass or pain in the axilla. Lauren Barney. April 17, 2013. Breast Cancer Subtypes. Breast cancer is classified into clinical subtypes based upon receptor expression. These subtypes dictate possible therapeutic options and vary in their prognosis. Dr. Ruth . Heisey. Family Physician/GP Oncologist. Women’s College Hospital/Princess Margaret . Cancer Centre. Clinician Investigator/Associate Professor. University of Toronto. Sandy Fawcett . RN(EC) NP-Adult. Generosa. . Grana. , MD. Professor, Cooper Medical School of Rowan University. Director, MD Anderson Cancer Center at Cooper. Overview. Factors that affect breast cancer risk. Tools to assess risk. Role of genetics in this process. October 25,2017. Disclosures. None. Outline. Epidemiology. Risk Factors. Screening. Diagnosis. Treatment. Genetic testing. Research. Epidemiology. 2017 :estimated 252.710 new cases of invasive breast cancer in women. What’s Positive about Triple Negative Breast Cancer ? Julie R. Gralow, M.D. Jill Professor Endowed Professor of Breast Cancer Director, Breast Medical Oncology Seattle Cancer Care Alliance University of Washington School of Medicine Lauren Barney. April 17, 2013. Breast Cancer Subtypes. Breast cancer is classified into clinical subtypes based upon receptor expression. These subtypes dictate possible therapeutic options and vary in their prognosis. Nature of clinical assessment and diagnosis. Diagnosis is as necessary to mental health intervention as to action in any other realm. It is an inevitable part of the clinical process. It can involve . L. MEYSKENS, D. (32, 33), and hormonal (42, 46, (60, 78). 57, 66, cancer in is less Klinefelter'n syndrome with male authors measured et al. the formation ofestrone results rerrmin in males been repo Paget ’ Clinical suspicion of Paget ’ s disease 1 PATIENT PRESENTATION Page 1 of 4 Department of Clinical Effectiveness V 8 Approved by Executive Committee of the Medical Staff on 03 / 23 / Infusion Therapies. Aditya Bardia MD, MPH . Massachusetts General Hospital, . Dana Farber/Harvard Cancer Center,. Harvard Medical School, Boston, MA. .. . No Disclosure. No Relevant Disclosures. . To understand the principle of targeted therapies and importance of routine tumor genotyping in cancer . Pathway for patients with suspected Breast Cancer. Median Wait. (days). Breast Cancer Ideal Pathway . [final]. 2ww referral received in secondary care. Clinical examination imaging +/- biopsies. Is cancer confirmed or still suspected?. Presenter: Carolyn . Taylor. . Paul . McGale. , Jake Probert, John . Broggio, . Jackie . Charman. , . Sarah Darby. , Amanda Kerr, Tim Whelan, . David Cutter, . Gurdeep. . Mannu. , David . Dodwell. 1.